Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Turner

Showing results (171-180 of 362) with videos related to

Pageof 37
Sort By:
The Pediatric Infectious Disease Journal|February 10, 2018
Cytomegalovirus Infection in Pediatric Severe Ulcerative Colitis-A Multicenter Study from the Pediatric Inflammatory Bowel Disease Porto Group of the European Society of Pediatric Gastroenterology, Hepatology and NutritionShlomi Cohen, Christine Martinez-Vinson, Marina Aloi, et al.
Journal of Crohn'S & Colitis|February 26, 2024
The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide CohortsOhad Atia, Nicklas Bryder, Adi Mendelovici, et al.
Plos One|October 14, 2010
Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitisBoyko Kabakchiev, Dan Turner, Jeffrey Hyams, et al.
The American Journal of Gastroenterology|April 8, 2010
Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric propertiesDan Turner, Anne M Griffiths, Thomas D Walters, et al.
Rheumatology (Oxford, England)|May 30, 2024
Familial Mediterranean fever in patients with inflammatory bowel diseases: a nationwide study from the epi-IIRNMichal Kori, Rachel Buchuk, Ofra Goldzweig, et al.
Open Forum Infectious Diseases|August 4, 2023
Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort StudyLuba Tau, David Hagin, Tal Freund, et al.
Gastroenterology|June 23, 2019
Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel DiseasesParambir S Dulai, Laurent Peyrin-Biroulet, Silvio Danese, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
World Journal of Methodology|January 17, 2024
Inflammatory bowel disease among first generation immigrants in Israel: A nationwide epi-Israeli Inflammatory Bowel Disease Research Nucleus studyMira Stulman, Gili Focht, Yiska Loewenberg Weisband, et al.
Inflammatory Bowel Diseases|January 8, 2024
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN CohortOhad Atia, Chagit Friss, Gili Focht, et al.
Pageof 37

Showing results (171-180 of 362) with videos related to

Sort By:
Pageof 37
The Pediatric Infectious Disease Journal|February 10, 2018
Cytomegalovirus Infection in Pediatric Severe Ulcerative Colitis-A Multicenter Study from the Pediatric Inflammatory Bowel Disease Porto Group of the European Society of Pediatric Gastroenterology, Hepatology and NutritionShlomi Cohen, Christine Martinez-Vinson, Marina Aloi, et al.
Journal of Crohn'S & Colitis|February 26, 2024
The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide CohortsOhad Atia, Nicklas Bryder, Adi Mendelovici, et al.
Plos One|October 14, 2010
Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitisBoyko Kabakchiev, Dan Turner, Jeffrey Hyams, et al.
The American Journal of Gastroenterology|April 8, 2010
Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric propertiesDan Turner, Anne M Griffiths, Thomas D Walters, et al.
Rheumatology (Oxford, England)|May 30, 2024
Familial Mediterranean fever in patients with inflammatory bowel diseases: a nationwide study from the epi-IIRNMichal Kori, Rachel Buchuk, Ofra Goldzweig, et al.
Open Forum Infectious Diseases|August 4, 2023
Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort StudyLuba Tau, David Hagin, Tal Freund, et al.
Gastroenterology|June 23, 2019
Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel DiseasesParambir S Dulai, Laurent Peyrin-Biroulet, Silvio Danese, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
World Journal of Methodology|January 17, 2024
Inflammatory bowel disease among first generation immigrants in Israel: A nationwide epi-Israeli Inflammatory Bowel Disease Research Nucleus studyMira Stulman, Gili Focht, Yiska Loewenberg Weisband, et al.
Inflammatory Bowel Diseases|January 8, 2024
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN CohortOhad Atia, Chagit Friss, Gili Focht, et al.
Pageof 37